Accelerating Innovation Set To Boost The Growth Of The Global Chemiluminescence Immunoassay Market
 |
| Chemiluminescence Immunoassay Market |
The
global Chemiluminescence Immunoassay Market is estimated to be valued at US$ 7.01 Bn or Mn in 2023 and is
expected to exhibit a CAGR of 8.0%
over the forecast period 2023 to 2030,
as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Chemiluminescence Immunoassay (CLIA) is a technique used for detection and
quantification of various analytes through binding between an antibody and
antigen. CLIA is highly sensitive, specific, and cost-effective method for
detection of biomarkers associated with various diseases and disorders. It is
commonly used in research and clinical applications for detection of cardiac
markers, tumor markers, hormonal assays, and infectious disease markers due to
its accuracy and reproducibility.
Market key trends:
One of the key trends in the chemiluminescence immunoassay market is increasing
adoption of CLIA for the detection of infectious diseases. CLIA is widely used
diagnostic method for detection of infectious diseases including HIV,
hepatitis, infectious mononucleosis, and respiratory infections. Growing
prevalence of infectious diseases globally is expected to drive the adoption of
CLIA testing. Furthermore, ongoing research and development activities for
development of CLIA systems with high specificity, sensitivity and automation
is also expected to support market growth over the forecast period. Market
players are focusing on developing innovative products with advanced features
to gain competitive edge in the market.
Porter's Analysis
Threat of new entrants: The chemiluminescence immunoassay market requires high
R&D investment and technological expertise which poses as a entry barrier
for new players.
Bargaining power of buyers: Buyers have moderate bargaining power due to
availability of alternative technologies like ELISA. However, chemiluminescence
offers automation, accuracy and efficiency which attract buyers.
Bargaining power of suppliers: Presence of many components suppliers limits
their bargaining power. Suppliers depend on manufacturers for bulk sales.
Threat of new substitutes: Technologies like ELISA, fluorescent immunoassay are
substitutes but they lack accuracy, automation and efficiency of
chemiluminescence immunoassay.
Competitive rivalry: The market is consolidated with few global players
dominating the market. Intense competition exists based on product quality,
reliability and pricing.
Key Takeaways
The
Global Chemiluminescence Immunoassay Market Demand is expected to witness
high growth, exhibiting CAGR of 8.0%
over the forecast period, due to increasing need for automated immunoassay
systems.
North America dominates the market and is expected to continue its dominance
during the forecast period owing to rising cases of chronic and infectious
diseases. Asia Pacific is anticipated to witness fastest growth due to growing
healthcare industry and increasing healthcare expenditure in countries like
China and India.
Key players operating in the chemiluminescence immunoassay market are DiaSorin
S.p.A., Abbott Laboratories, Shenzhen Mindray Bio-Medical Electronics Co.,
Ltd., Siemens Healthineers, Beckman Coulter Inc., F. Hoffmann-La Roche AG,
Inova Diagnostics, Inc., Maccura Biotechnology Co., Ltd., Tosoh Corporation.
DiaSorin S.p.A. dominates the market.
Read
More:
Comments
Post a Comment